Rescued expression of Rap1GAP in renal cell carcinoma cell lines using a demethylating drug, decitabine (5-azadC), resulted in a significant reduction in tumor invasiveness [61]. This evidence concerns the gene RAP1GAP and hereditary clear cell renal cell carcinoma.